Nephrogenic systemic fibrosis in stage 4 kidney disease, what is the alternative?
Stassen
P M
PM
D003287:Contrast Media / Q000009:adverse effects*; D018450:Disease Progression; D064420:Drug-Related Side Effects and Adverse Reactions; D005355:Fibrosis / Q000139:chemically induced*; D019786:Gadolinium DTPA / Q000009:adverse effects*; D006801:Humans; D007674:Kidney Diseases / Q000150:complications* / Q000503:physiopathology; D012720:Severity of Illness Index
D003287:Contrast Media; D019786:Gadolinium DTPA